ABMD logo

Abiomed (ABMD) Cash And Cash Equivalents

ABMD Annual Cash & Cash Equivalents

$132.82 M
-$99.89 M-42.93%

31 March 2022

ABMD Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABMD Quarterly Cash And Cash Equivalents

$182.34 M
+$1.84 M+1.02%

30 September 2022

ABMD Quarterly Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABMD Cash And Cash Equivalents Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-42.9%-24.6%
3 y3 years+9.8%+21.3%
5 y5 years+240.2%+309.4%

ABMD Cash And Cash Equivalents High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-42.9%-24.6%

Abiomed Cash And Cash Equivalents History

DateAnnualQuarterly
Sept 2022
-
$182.34 M(+1.0%)
June 2022
-
$180.49 M(+35.9%)
Mar 2022
$132.82 M(-42.9%)
$132.82 M(-7.9%)
Dec 2021
-
$144.25 M(-40.4%)
Sept 2021
-
$241.88 M(+37.9%)
June 2021
-
$175.45 M(-24.6%)
Mar 2021
$232.71 M(+21.0%)
$232.71 M(+28.6%)
Dec 2020
-
$181.02 M(-10.5%)
Sept 2020
-
$202.24 M(-5.9%)
June 2020
-
$214.83 M(+11.7%)
Mar 2020
$192.34 M(+58.9%)
$192.34 M(+63.0%)
Dec 2019
-
$117.97 M(-21.5%)
Sept 2019
-
$150.28 M(+48.7%)
June 2019
-
$101.05 M(-16.5%)
Mar 2019
$121.02 M(+181.6%)
$121.02 M(+43.8%)
Dec 2018
-
$84.18 M(+10.2%)
Sept 2018
-
$76.38 M(+24.6%)
June 2018
-
$61.29 M(+42.6%)
Mar 2018
$42.98 M(+10.1%)
$42.98 M(-14.9%)
Dec 2017
-
$50.50 M(+13.4%)
Sept 2017
-
$44.54 M(+1.3%)
June 2017
-
$43.97 M(+12.6%)
Mar 2017
$39.04 M(-19.1%)
$39.04 M(-36.1%)
Dec 2016
-
$61.07 M(+11.6%)
Sept 2016
-
$54.71 M(+42.9%)
June 2016
-
$38.27 M(-20.6%)
Mar 2016
$48.23 M(+115.3%)
$48.23 M(-9.4%)
Dec 2015
-
$53.23 M(-2.2%)
Sept 2015
-
$54.42 M(+34.6%)
June 2015
-
$40.43 M(+80.5%)
Mar 2015
$22.40 M(+7.1%)
$22.40 M(+15.0%)
Dec 2014
-
$19.48 M(+11.4%)
Sept 2014
-
$17.48 M(-49.7%)
June 2014
-
$34.74 M(+66.1%)
Mar 2014
$20.92 M(+121.3%)
$20.92 M(-7.6%)
Dec 2013
-
$22.63 M(+123.6%)
Sept 2013
-
$10.12 M(-13.7%)
June 2013
-
$11.73 M(+24.1%)
Mar 2013
$9.45 M(+57.8%)
$9.45 M(-12.1%)
Dec 2012
-
$10.76 M(+139.2%)
Sept 2012
-
$4.50 M(+12.7%)
June 2012
-
$3.99 M(-33.4%)
Mar 2012
$5.99 M(+2.7%)
$5.99 M(+17.6%)
Dec 2011
-
$5.09 M(-4.6%)
Sept 2011
-
$5.34 M(+28.6%)
June 2011
-
$4.15 M(-28.8%)
Mar 2011
$5.83 M(+21.8%)
$5.83 M(+39.1%)
Dec 2010
-
$4.19 M(+1.0%)
Sept 2010
-
$4.15 M(+5.3%)
June 2010
-
$3.94 M(-17.7%)
Mar 2010
$4.79 M(+168.2%)
$4.79 M(+48.0%)
Dec 2009
-
$3.24 M(+16.3%)
Sept 2009
-
$2.78 M(+41.1%)
June 2009
-
$1.97 M(+10.4%)
Mar 2009
$1.78 M(-12.6%)
$1.78 M(-34.7%)
Dec 2008
-
$2.73 M(-6.2%)
Sept 2008
-
$2.92 M(+79.2%)
June 2008
-
$1.63 M(-20.3%)
Mar 2008
$2.04 M(-97.1%)
$2.04 M(-63.4%)
Dec 2007
-
$5.58 M(-90.6%)
Sept 2007
-
$59.52 M(-4.4%)
June 2007
-
$62.23 M(-10.7%)
Mar 2007
$69.65 M
$69.65 M(+1045.3%)
Dec 2006
-
$6.08 M(-13.8%)
Sept 2006
-
$7.05 M(-27.5%)
DateAnnualQuarterly
June 2006
-
$9.73 M(+24.3%)
Mar 2006
$7.83 M(+2.8%)
$7.83 M(-0.9%)
Dec 2005
-
$7.91 M(-48.2%)
Sept 2005
-
$15.26 M(+124.9%)
June 2005
-
$6.79 M(-10.9%)
Mar 2005
$7.62 M(+10.5%)
$7.62 M(+6.8%)
Dec 2004
-
$7.13 M(+51.0%)
Sept 2004
-
$4.72 M(-24.1%)
June 2004
-
$6.22 M(-9.7%)
Mar 2004
$6.89 M(-84.5%)
$6.89 M(-54.7%)
Dec 2003
-
$15.21 M(-64.0%)
Sept 2003
-
$42.26 M(+1.0%)
June 2003
-
$41.85 M(-6.1%)
Mar 2003
$44.57 M(-2.4%)
$44.57 M(-10.8%)
Dec 2002
-
$49.99 M(+2.9%)
Sept 2002
-
$48.59 M(-8.8%)
June 2002
-
$53.30 M(+16.7%)
Mar 2002
$45.67 M(-49.5%)
$45.67 M(+8.2%)
Dec 2001
-
$42.20 M(-18.2%)
Sept 2001
-
$51.61 M(-14.4%)
June 2001
-
$60.29 M(-33.4%)
Mar 2001
$90.46 M(-11.2%)
$90.46 M(+3.7%)
Dec 2000
-
$87.23 M(-4.1%)
Sept 2000
-
$90.99 M(-1.0%)
June 2000
-
$91.91 M(-9.8%)
Mar 2000
$101.92 M(+995.9%)
$101.92 M(+1935.9%)
Dec 1999
-
$5.01 M(-2.2%)
Sept 1999
-
$5.12 M(-10.4%)
June 1999
-
$5.71 M(-38.6%)
Mar 1999
$9.30 M(+244.4%)
$9.30 M(+166.5%)
Dec 1998
-
$3.49 M(+103.3%)
Sept 1998
-
$1.72 M(-28.1%)
June 1998
-
$2.39 M(-11.5%)
Mar 1998
$2.70 M(+68.8%)
$2.70 M(+7042.9%)
Dec 1997
-
$37.80 K(-94.7%)
Sept 1997
-
$711.40 K(-55.7%)
June 1997
-
$1.61 M(+0.3%)
Mar 1997
$1.60 M(-45.5%)
$1.60 M(+19.3%)
Dec 1996
-
$1.34 M(-81.6%)
Sept 1996
-
$7.30 M(+428.6%)
June 1996
-
$1.38 M(-53.0%)
Mar 1996
$2.94 M(+389.7%)
$2.94 M(+70.9%)
Dec 1995
-
$1.72 M(+415.1%)
Sept 1995
-
$333.80 K(-45.7%)
June 1995
-
$614.90 K(+2.5%)
Mar 1995
$600.00 K(+20.0%)
$600.00 K(0.0%)
Dec 1994
-
$600.00 K(+50.0%)
Sept 1994
-
$400.00 K(-77.8%)
June 1994
-
$1.80 M(+260.0%)
Mar 1994
$500.00 K(-28.6%)
$500.00 K(-28.6%)
Dec 1993
-
$700.00 K(+75.0%)
Sept 1993
-
$400.00 K(-75.0%)
June 1993
-
$1.60 M(+128.6%)
Mar 1993
$700.00 K(-85.1%)
$700.00 K(-80.0%)
Dec 1992
-
$3.50 M(+9.4%)
Sept 1992
-
$3.20 M(-25.6%)
June 1992
-
$4.30 M(-8.5%)
Mar 1992
$4.70 M(-42.0%)
$4.70 M(-14.5%)
Dec 1991
-
$5.50 M(-11.3%)
Sept 1991
-
$6.20 M(+37.8%)
June 1991
-
$4.50 M(-44.4%)
Mar 1991
$8.10 M(-67.1%)
$8.10 M(-67.1%)
Mar 1990
$24.60 M(+136.5%)
$24.60 M(+136.5%)
Mar 1989
$10.40 M(-21.8%)
$10.40 M(-21.8%)
Mar 1988
$13.30 M(+454.2%)
$13.30 M(+454.2%)
Mar 1987
$2.40 M
$2.40 M

FAQ

  • What is Abiomed annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Abiomed?
  • What is Abiomed annual cash & cash equivalents year-on-year change?
  • What is Abiomed quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Abiomed?
  • What is Abiomed quarterly cash and cash equivalents year-on-year change?

What is Abiomed annual cash & cash equivalents?

The current annual cash & cash equivalents of ABMD is $132.82 M

What is the all time high annual cash & cash equivalents for Abiomed?

Abiomed all-time high annual cash & cash equivalents is $232.71 M

What is Abiomed annual cash & cash equivalents year-on-year change?

Over the past year, ABMD annual cash & cash equivalents has changed by -$99.89 M (-42.93%)

What is Abiomed quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of ABMD is $182.34 M

What is the all time high quarterly cash and cash equivalents for Abiomed?

Abiomed all-time high quarterly cash and cash equivalents is $241.88 M

What is Abiomed quarterly cash and cash equivalents year-on-year change?

Over the past year, ABMD quarterly cash and cash equivalents has changed by -$59.55 M (-24.62%)